Insights on Clinical Trials

  1. 5 Essential Capabilities For Decentralized Clinical Trials 2/3/2025

    Learn how to develop and utilize a successful DCT framework, enabling your study to enhance patient access, improve data quality, and streamline study operations.

  2. Data-Driven Physician Engagement For Ultra-Rare Diseases 2/3/2025

    How can an effective partnership help you to utilize advanced data analytics to address the significant challenges of clinical trials centered around ultra-rare diseases?

  3. Expanding Patient Access To Cell And Gene Therapies: Optimizing Channel Strategy 1/31/2025

    Rare disease innovation demands robust channel strategies for patient access. Learn how a patient-centric approach, logistical solutions, and strong partnerships are key to successful patient access.

  4. Oncolytic Virus Therapy: Global Clinical Trial Landscape (2024) 1/30/2025

    Addressing immunological challenges and navigating the evolving regulatory environment is critical for its successful integration into clinical practice.

  5. Triple-Negative Breast Cancer: Global Clinical Trial Landscape 1/30/2025

    With over 1,500 TNBC-focused clinical trials since 2019, research efforts into Triple-negative breast cancer (TNBC) treatments are accelerating despite challenges such as drug resistance.

  6. The Evolution Of Cell And Gene Therapy: Pioneering Breakthroughs For A New Era In Medicine 1/30/2025

    This article explores the rapid evolution of cell and gene therapy (CGT), highlighting its expansion beyond hematology and oncology into autoimmune and metabolic diseases, emphasizing the need for safety, patient access, and a collaborative, knowledge-sharing approach to accelerate innovation and ensure broader therapeutic impact via the "Knowledge Research Organization."

  7. Why Mobile Eye Exams Are Critical In Clinical Trials With Ocular Endpoints 1/29/2025

    Explore how mobile eye exams can expand access to eye care and improve the geographical reach of clinical trials.

  8. Streamlining Phase 1 Trials With The Mobile Vision Pod 1/29/2025

    A contract research organization formed a partnership to address significant challenges during a Phase 1 clinical trial for a corneal disease treatment through the use of a Mobile Vision Pod.

  9. Expanding Diabetes-Related Eye Health Equity 1/29/2025

    20/20 Onsite, American Diabetes Association and Genentech collaborated on an event to provide immediate diagnostic services, including retinal imaging and visual acuity assessments, directly on-site.

  10. Overcoming Unexpected Obstacles In A Phase 1 Study 1/29/2025

    Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.